| Patient | Samuel Langhorne Clemens |
|---|---|
| Date of birth | 1835-11-30 |
| Identifiers | MRN HR-NI013-SYN-TD; SSN (made up) 000-13-2964 |
| Document date | 1905-10-16 |
| Author | Winifred Achterberg-Lowe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eighteen-week review: grief, no smoking, urate toward target and his writing. [S]
Mr. Clemens returns three weeks after his wellness visit, a few days before he leaves for his winter home. He has had fifteen grief therapy sessions and will finish the sixteenth next week. He visits the places he used to avoid, has given some of his wife's things to people who will use them, and is finishing a long essay. He dines with friends every week. He sleeps about six hours. He has smoked no cigars for eight weeks and has finished twelve weeks of varenicline. He has had no gout since August and no chest tightness. His stool test and hepatitis C antibody were negative, and the ultrasound showed a normal aorta. [S]
| Element | Detail |
|---|---|
| Grief | Fifteen sessions; PG-13-R 26 |
| Tobacco | No cigars for eight weeks |
| Gout | No flares since August |
| Screening | Stool test and hepatitis C antibody negative; aorta normal on ultrasound |
| Urate today | 6.4 mg/dL |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight up |
| Cardiovascular | Negative | No chest tightness |
| Musculoskeletal | Negative | No joint pain or muscle aches |
| Psychiatric | Negative | Sad at times, especially in the evenings, but able to work and enjoy friends; no thoughts of death |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily on days 1 to 3, then twice daily on days 4 to 7 | Oral route | 1905-07-17 to 1905-07-24 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily with food for twelve weeks, with a quit date in the second week | One tablet twice daily with food | Oral route | 1905-07-24 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1905-07-17 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1905-07-17 | active | S |
| Allopurinol 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1905-07-17 to 1905-09-11 | completed | S |
| Allopurinol 100 mg oral tablet, two tablets daily (200 mg) | Two tablets daily | Oral route | 1905-09-11 to 1905-10-16 | completed | S |
| Allopurinol 300 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1905-10-16 | active | S |
| Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six months | One tablet daily | Oral route | 1905-07-17 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days, for a gout flare, prescribed by a doctor where he was staying | Two tablets each morning for five days | Oral route | 1905-08-12 to 1905-08-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1905-10-16 | Body height | 173 | cm | S |
| 1905-10-16 | Body weight | 65.4 | kg | S |
| 1905-10-16 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 1905-10-16 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1905-10-16 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1905-10-16 | Heart rate | 70 | /min | S |
| 1905-10-16 | Respiratory rate | 14 | /min | S |
| 1905-10-16 | Body temperature | 36.6 | Cel | S |
| 1905-10-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1905-10-16 | Urate [Mass/volume] in Serum or Plasma | 6.4 | mg/dL | 3.5-7.2 mg/dL | Normal | S |
| 1905-10-16 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1905-10-16 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1905-10-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.09 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1905-10-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1900)/1.73 sq M | 73 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1905-10-16 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1905-10-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Vital signs recorded on 1905-10-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/76, pulse 70; weight 65.4 kg, BMI 21.9 |
| Musculoskeletal | No tophi; joints normal |
| Psychiatric | Warm and witty; speaks of his wife in the past tense with affection |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persistent yearning for his wife, broken sleep, low mood and withdrawal from friends and work, a year after her death; cause under evaluation | resolved | confirmed | Z63.4 | S — Synthetic presenting problem anchored to his wife's documented death a year before; resolved into the diagnosis of prolonged grief disorder at the consultation. Not a claim about his real grief. |
| Prolonged grief disorder (DSM-5-TR): more than 12 months after his wife's death, daily yearning and preoccupation with her, with intense emotional pain, a sense that part of himself has died, avoidance of reminders, loneliness, difficulty taking up his work and life again, and a feeling that life is meaningless; PG-13-R 41; major depression not present | active | confirmed | F43.81 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented bereavements. Not a claim about his real mental health; the roster's bipolar lead is not used. |
| Tobacco use disorder, cigars: about fifteen cigars a day, smoking since boyhood, some smoke inhaled; first cigar within thirty minutes of waking | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented smoking since boyhood. |
| Chest tightness on climbing steep hills, twice in the past month, easing within five minutes of rest; none at rest; cause under evaluation | resolved | confirmed | R07.89 | S — Synthetic presenting symptom; resolved into a diagnosis at five weeks after CT coronary angiography. Not a claim about his real heart in 1905; his documented chest pain began in 1909. |
| Coronary artery disease, nonobstructive (CAD-RADS 2: 25 to 49 percent narrowing of the proximal left anterior descending artery; coronary calcium score 410), with exertional chest tightness that has not recurred on treatment; treated with a statin, aspirin and stopping smoking | active | confirmed | I25.10 | S — Synthetic modern diagnosis made at five weeks. Not a claim about his real coronary arteries. |
| Gout, recurrent flares of the big toe since his late fifties, two in the past year; serum urate 8.6 mg/dL; no tophi | active | confirmed | M10.9 | S — Synthetic modern diagnosis anchored to his documented gout. |
| Acute bronchitis, likely viral, for six days in a cigar smoker; no pneumonia on examination; resolved within three weeks without antibiotics | resolved | confirmed | J20.9 | S — Synthetic acute illness; not a historical claim; his documented bronchitis was in later years. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Grief severity (PG-13-R) and the DSM-5-TR prolonged grief disorder criteria | At diagnosis and every four weeks during therapy | Completed today | PG-13-R 26, below the threshold of 30 |
| Referral | Prolonged grief disorder therapy: sessions attended | Weekly for sixteen weeks | Completed today | Fifteen sessions; the last next week |
| Survey | Depression (PHQ-9), to watch for major depression | At baseline and every four weeks during treatment | Completed today | PHQ-9 5, item 9 scored 0 |
| Survey | Suicide risk review, safety plan, means safety and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of death; safety plan to carry through the anniversary |
| Self-management | Sleep, without sedative-hypnotics | Every visit | Completed today | About six hours |
| Self-management | Social contact and his writing | Every visit | Completed today | Weekly dinners with friends; finishing an essay |
| Self-management | Tobacco use (cigars a day), readiness and counseling | Every visit | Completed today | No cigars for eight weeks |
| Medication safety | Varenicline: adherence, nausea, sleep and mood changes | Every visit | Completed today | No side effects now; extended twelve weeks |
| Examination | Chest symptoms on exertion | Every visit | Completed today | None |
| Examination | Blood pressure | Every visit | Completed today | 128/76 mmHg |
| Laboratory | Lipid panel and ALT on a statin | 4 to 12 weeks after starting, then every 3 to 12 months | Up to date | LDL 74 mg/dL at thirteen weeks; next in six to twelve months |
| Medication safety | Aspirin and statin adherence, bleeding and muscle symptoms | Every visit | Completed today | Taking both; no bleeding or muscle aches |
| Laboratory | Serum urate during allopurinol titration | Every 2 to 5 weeks while titrating, then every 6 months | Completed today | 6.4 mg/dL on 200 mg; raised to 300 mg |
| Self-management | Gout flares and colchicine prophylaxis | Every visit | Completed today | No flares since August; colchicine continued |
| Laboratory | Kidney function on allopurinol and colchicine | With each urate check | Completed today | Sodium 140, potassium 4.4 mmol/L, creatinine 1.09 mg/dL, eGFR 73, glucose 96 mg/dL |
Goal progress:
Immunizations given today: RSV vaccine, single dose, for an adult aged 60 to 74 with coronary disease; Recombinant zoster vaccine, first of two doses [S]
Guideline basis: Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022); Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021); Treatment of complicated grief: a randomized controlled trial (2005); Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016); Loss of partner and suicide risks among oldest old: a population-based register study (2004); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026); Adult Immunization Schedule by Age (2026)
Follow-up: RSV vaccine and first zoster dose given today. Urate in four to five weeks. Review in three months, by video if he is away. Call the clinic or 988 at any time. [S]